FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3175518744> ?p ?o ?g. }

• W3175518744 abstract "Antiretroviral-based HIV prevention, including pre-exposure prophylaxis (PrEP), is expanding in generalized epidemic settings, but additional prevention options are needed for individuals with periodic, high-risk sexual exposures. Non-occupational post-exposure prophylaxis (PEP) is recommended in global guidelines. However, in Africa, awareness of and access to PEP for sexual exposures are limited. We assessed feasibility, acceptability, uptake and adherence in a pilot study of a patient-centred PEP programme with options for facility- or community-based service delivery.After population-level HIV testing with universal access to PrEP for persons at elevated HIV risk (SEARCH Trial:NCT01864603), we conducted a pilot PEP study in five rural communities in Kenya and Uganda between December 2018 and May 2019. We assessed barriers to PEP in the population and implemented an intervention to address these barriers, building on existing in-country PEP protocols. We used community leaders for sensitization. Test kits and medications were acquired through the Ministry of Health supply chain and healthcare providers based at the Ministry of Health clinics were trained on PEP delivery. Additional intervention components were (a)PEP availability seven days/week, (b)PEP hotline staffed by providers and (c)option for out-of-facility medication delivery. We assessed implementation using the Proctor framework and measured seroconversions via repeat HIV testing. Successful PEP completion was defined as self-reported adherence over four weeks of therapy with post-PEP HIV testing.Community leaders were able to sensitize and mobilize for PEP. The Ministry of Health supplied test kits and PEP medications; after training, healthcare providers delivered the 28-day regimen with high completion rates. Among 124 persons who sought PEP, 66% were female, 24% were ≤25 years and 42% were fisherfolk. Of these, 20% reported exposure with a serodifferent partner, 72% with a new or existing relationship and 7% from transactional sex. 12% of all visits were conducted at out-of-facility community-based sites; 35% of participants had ≥1 out-of-facility visit. No serious adverse events were reported. Overall, 85% met the definition of PEP completion. There were no HIV seroconversions.Among individuals with elevated-risk exposures in rural East African communities, patient-centred PEP was feasible, acceptable and provides a promising addition to the current prevention toolkit." @default.
• W3175518744 created "2021-07-05" @default.
• W3175518744 creator A5000997859 @default.
• W3175518744 creator A5002591240 @default.
• W3175518744 creator A5003734191 @default.
• W3175518744 creator A5005688369 @default.
• W3175518744 creator A5030911929 @default.
• W3175518744 creator A5036835389 @default.
• W3175518744 creator A5042666638 @default.
• W3175518744 creator A5054347620 @default.
• W3175518744 creator A5064264671 @default.
• W3175518744 creator A5068971702 @default.
• W3175518744 creator A5069551580 @default.
• W3175518744 creator A5071235932 @default.
• W3175518744 creator A5074052328 @default.
• W3175518744 creator A5083823135 @default.
• W3175518744 date "2021-06-01" @default.
• W3175518744 modified "2023-10-14" @default.
• W3175518744 title "Uptake and outcomes of a novel community‐based HIV post‐exposure prophylaxis (PEP) programme in rural Kenya and Uganda" @default.
• W3175518744 cites W1995179748 @default.
• W3175518744 cites W1999703548 @default.
• W3175518744 cites W2065224267 @default.
• W3175518744 cites W2117057469 @default.
• W3175518744 cites W2126379082 @default.
• W3175518744 cites W2140092196 @default.
• W3175518744 cites W2291394860 @default.
• W3175518744 cites W2549666191 @default.
• W3175518744 cites W2611491071 @default.
• W3175518744 cites W2782776732 @default.
• W3175518744 cites W2801281961 @default.
• W3175518744 cites W2901406287 @default.
• W3175518744 cites W2943749739 @default.
• W3175518744 cites W3000149191 @default.
• W3175518744 cites W3007818090 @default.
• W3175518744 cites W3022697548 @default.
• W3175518744 doi "https://doi.org/10.1002/jia2.25670" @default.
• W3175518744 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8215805" @default.
• W3175518744 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34152067" @default.
• W3175518744 hasPublicationYear "2021" @default.
• W3175518744 type Work @default.
• W3175518744 sameAs 3175518744 @default.
• W3175518744 citedByCount "10" @default.
• W3175518744 countsByYear W31755187442022 @default.
• W3175518744 countsByYear W31755187442023 @default.
• W3175518744 crossrefType "journal-article" @default.
• W3175518744 hasAuthorship W3175518744A5000997859 @default.
• W3175518744 hasAuthorship W3175518744A5002591240 @default.
• W3175518744 hasAuthorship W3175518744A5003734191 @default.
• W3175518744 hasAuthorship W3175518744A5005688369 @default.
• W3175518744 hasAuthorship W3175518744A5030911929 @default.
• W3175518744 hasAuthorship W3175518744A5036835389 @default.
• W3175518744 hasAuthorship W3175518744A5042666638 @default.
• W3175518744 hasAuthorship W3175518744A5054347620 @default.
• W3175518744 hasAuthorship W3175518744A5064264671 @default.
• W3175518744 hasAuthorship W3175518744A5068971702 @default.
• W3175518744 hasAuthorship W3175518744A5069551580 @default.
• W3175518744 hasAuthorship W3175518744A5071235932 @default.
• W3175518744 hasAuthorship W3175518744A5074052328 @default.
• W3175518744 hasAuthorship W3175518744A5083823135 @default.
• W3175518744 hasBestOaLocation W31755187441 @default.
• W3175518744 hasConcept C138885662 @default.
• W3175518744 hasConcept C141668000 @default.
• W3175518744 hasConcept C27206212 @default.
• W3175518744 hasConcept C2775949068 @default.
• W3175518744 hasConcept C2776939746 @default.
• W3175518744 hasConcept C2776983459 @default.
• W3175518744 hasConcept C2778283251 @default.
• W3175518744 hasConcept C2779496540 @default.
• W3175518744 hasConcept C2908647359 @default.
• W3175518744 hasConcept C2986740045 @default.
• W3175518744 hasConcept C3013748606 @default.
• W3175518744 hasConcept C41008148 @default.
• W3175518744 hasConcept C512399662 @default.
• W3175518744 hasConcept C521751864 @default.
• W3175518744 hasConcept C71924100 @default.
• W3175518744 hasConcept C76155785 @default.
• W3175518744 hasConcept C99454951 @default.
• W3175518744 hasConceptScore W3175518744C138885662 @default.
• W3175518744 hasConceptScore W3175518744C141668000 @default.
• W3175518744 hasConceptScore W3175518744C27206212 @default.
• W3175518744 hasConceptScore W3175518744C2775949068 @default.
• W3175518744 hasConceptScore W3175518744C2776939746 @default.
• W3175518744 hasConceptScore W3175518744C2776983459 @default.
• W3175518744 hasConceptScore W3175518744C2778283251 @default.
• W3175518744 hasConceptScore W3175518744C2779496540 @default.
• W3175518744 hasConceptScore W3175518744C2908647359 @default.
• W3175518744 hasConceptScore W3175518744C2986740045 @default.
• W3175518744 hasConceptScore W3175518744C3013748606 @default.
• W3175518744 hasConceptScore W3175518744C41008148 @default.
• W3175518744 hasConceptScore W3175518744C512399662 @default.
• W3175518744 hasConceptScore W3175518744C521751864 @default.
• W3175518744 hasConceptScore W3175518744C71924100 @default.
• W3175518744 hasConceptScore W3175518744C76155785 @default.
• W3175518744 hasConceptScore W3175518744C99454951 @default.
• W3175518744 hasFunder F4320306137 @default.
• W3175518744 hasFunder F4320337355 @default.
• W3175518744 hasIssue "6" @default.
• W3175518744 hasLocation W31755187441 @default.
• W3175518744 hasLocation W31755187442 @default.
• W3175518744 hasLocation W31755187443 @default.

• next